Christopher L. Pulliam; Dustin A. Heldman; Elizabeth B. Brokaw; Thomas O. Mera; Zoltan K. Mari; Michelle A. Burack IEEE Trans Biomed Eng. 2018 Jan;65(1):159-164.
Christopher L. Pulliam; Dustin A. Heldman; Elizabeth B. Brokaw; Thomas O. Mera; Zoltan K. Mari; Michelle A. Burack IEEE Trans Biomed Eng. 2018 Jan;65(1):159-164.
VIEW PDF 21 FEB 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has recently received two Deep Brain Stimulation (DBS) tuning patents. DBS is used on patients with Parkinson’s disease and other movement disorders to help mitigate their symptoms. …
VIEW PDF 11 JAN 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has been awarded Patent 9,522,278 (Movement Disorder Therapy System and Methods of Tuning Remotely, Intelligently and/or Automatically) from the US Patent Office, the seventh patent awarded to…
Tamás G, Kelemen A, Radics P, Valálik I, Heldman D, Klivényi P, Vécsei L, Hidasi E, Halász L, Kis D, Barsi P, Golopencza P, Erőss L. Brain Res. 2016 Oct 1;1648(Pt A):438-44. doi: 10.1016/j.brainres.2016.08.019. Epub 2016 Aug 16.
VIEW PDF 26 SEPT 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) today announced plans to collaborate with the pharmaceutical company UCB to provide individuals with Parkinson’s Disease (PD) and their clinicians with improved quantitative tools for assessing the…
VIEW PDF 31 AUG 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) held their 5th annual WhyNext? Event on August 22 focusing on Parkinson’s Disease (PD). WhyNext? brought together the entire GLNT team of engineers, researchers, software developers, commercial…
Heldman DA, Giuffrida JP, Cubo E Journal of Parkinsons Disease. 2016 Jul 2. [Epub ahead of print]
VIEW PDF 20 JUL 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has completed and published a clinical study validating that remote monitoring with wearable, objective measures can lead to an increased referral rate for advanced therapies in Parkinson’s…
VIEW PDF 15 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that three scientific research studies validating Kinesia wearable tech for Parkinson’s disease applications will be highlighted at the 20th International Congress of Parkinson’s Disease and…
VIEW PDF 10 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they have received four issued patents from the U.S. Patent Office, focused on wearable technology for Parkinson’s disease diagnostics and treatment. The issued intellectual property…